ST
AMPE

Spot Trading’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Spot Trading’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-48
Closed -$51K – 4505
2014
Q3 		$51K Buy
+48
New +$80.8K ﹤0.01% 3770

Other funds holding AMPE

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NFG
Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Spot Trading's AMPE Position: Q4 2014 in Review

Spot Trading sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2014, closing a stake of 48 shares — an estimated $51K sold.

Spot Trading first reported a position in AMPE in Q3 2014 and held it in 1 quarter. The position peaked at $51K in Q3 2014. 69 funds tracked by Wall St. Rank hold AMPE as of Q4 2014.

  • Spot Trading reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2014 after selling out during the quarter.
  • Spot Trading sold 48 Ampio Pharmaceuticals Inc. shares in Q4 2014, an estimated $51K.
  • Spot Trading first reported a position in Ampio Pharmaceuticals Inc. in Q3 2014 and held it in 1 quarter.
  • Spot Trading's Ampio Pharmaceuticals Inc. position peaked at $51K in Q3 2014.
  • 69 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2014.

Based on Spot Trading's 13F filing for Q4 2014, filed 13 Feb 2015.